LI Leishi
About
In The Last Decade
LI Leishi
134 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Nephrology 2.2k
- Rheumatology 1.2k
- Molecular Biology 643
- Immunology 618
- Pulmonary and Respiratory Medicine 464
Countries citing papers authored by LI Leishi
This map shows the geographic impact of LI Leishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LI Leishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LI Leishi more than expected).
Fields of papers citing papers by LI Leishi
This network shows the impact of papers produced by LI Leishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LI Leishi. The network helps show where LI Leishi may publish in the future.
Co-authorship network of co-authors of LI Leishi
This figure shows the co-authorship network connecting the top 25 collaborators of LI Leishi. A scholar is included among the top collaborators of LI Leishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LI Leishi. LI Leishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Triptolide ameliorates podocyte injury induced by the terminal complement factor C5b-9 in vitro | 5 |
| 2 | Triptolide ameliorates proteinuria and improves renal lesion in diabetic db/db mice | 1 |
| 3 | Obesity-related glomerulopathy:body mass index and proteinuria | 9 |
| 4 | Chronic complications in patients of type 2 diabetes with diabetic nephropathy | 1 |
| 5 | Effects of a combined regime of tripterygium wilfordii plus ARB and emodin in treatment of IgA nephropathy | 1 |
| 6 | A prospective study of multi-target therapy on refractory lupus nephritis | 1 |
| 7 | Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis | 2 |
| 8 | Continuous blood purification in the treatment of 1692 critical patients:A retrospective study | 1 |
| 9 | Mycophenolate mofetil versus intravenous pulse cyclophosphamide for class IV plus V lupus nephritis | 2 |
| 10 | Effect of immunoadsorption therapy in patients with lipoprotein glomerulopathy | 1 |
| 11 | Deposition of amylin in the renal tissues of patients with diabetic nephropathy | 1 |
| 12 | Clinical and immunological features of 1352 Chinese patients with lupus nephritis | 2 |
| 13 | Combined therapy of rhein and benazepril for treatment of diabetic nephropathy in db/db mice | 6 |
| 14 | Rate of declining residual renal function in patients on peritoneal dialysis | 0 |
| 15 | Assessment of insulin resistance in patients with obesity related glomerulopathy | 1 |
| 16 | A prospective preliminary study of tacrolimus (FK506) combined with low-dose prednisone in patients with membranous lupus nephropathy | 1 |
| 17 | Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. | 19 |
| 18 | Glomerular podocyte lesion in patients with diabetic nephropathy | 3 |
| 19 | Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis. | 5 |
| 20 | Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.